Giacomo Canesin
5PUBLICATIONS
26CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 04, 2026
A phase 1/2 study of donor-derived anti-CD33 CAR T-cell therapy (VCAR33) for relapsed/refractory AML after allogeneic HCT.Muhammad Umair Mushtaq, John F DiPersio, Jacques Azzi
|Oct 23, 2025
Remission of TP53-Mutant AML After Transplantation With Trem-Cel, a CRISPR/Cas9 Gene-Edited Allograft Lacking CD33, Followed by a Donor-Derived Anti-CD33 Chimeric Antigen Receptor T (VCAR33).Guenther Koehne, Muhammad U Mushtaq, Lori S Muffly
|May 14, 2022
Labile Heme and Heme Oxygenase-1 Maintain Tumor-Permissive Niche for Endometriosis-Associated Ovarian Cancer.Jonathan L Hecht, Monika Janikova, Reeham Choudhury
|Aug 07, 2021
HO-1 and Heme: G-Quadruplex Interaction Choreograph DNA Damage Responses and Cancer Growth.Giacomo Canesin, Anindhita Meena Muralidharan, Kenneth D Swanson
|Apr 07, 2019
Deletion of Biliverdin Reductase A in Myeloid Cells Promotes Chemokine Expression and Chemotaxis in Part via a Complement C5a--C5aR1 Pathway.Kavita Bisht, Giacomo Canesin, Tasneem Cheytan
Pageof 1
Frequent Collaborators
3 joint publications
Barbara Wegiel
2 joint publications
Melissa M Lee-Sundlov
2 joint publications
Michelle I Lin
2 joint publications
Nirali N Shah
2 joint publications
Jennifer S Whangbo
2 joint publications
Joseph C Rimando
2 joint publications
Joseph Maakaron
2 joint publications
Lori S Muffly
1 joint publications
Zsuzsanna Nemeth
1 joint publications
Julian Scherer
